In Vivo Antibacterial Activities of Sanfetrinem Cilexetil, a New Oral Tricyclic Antibiotic
In Vivo Antibacterial Activities of Sanfetrinem Cilexetil, a New Oral Tricyclic Antibiotic
复制标题
新型口服三环抗生素Sanfetrinem Cilexetil的体内抗菌活性
DOI：
10.1128/aac.42.7.1858
复制
发表时间：
1998
影响因子：
4.9
通讯作者：
K. Yamaguchi
中科院分区：
文献类型：
--
作者：
Shinobu Tamura;S. Miyazaki;K. Tateda;A. Ohno;Y. Ishii;Tetsuya Matsumoto;N. Furuya;K. Yamaguchi
ABSTRACT The in vivo antibacterial activities of a new oral trinem, sanfetrinem cilexetil (a prodrug of sanfetrinem), were evaluated in comparison with those of cefdinir and amoxicillin. Sanfetrinem cilexetil showed potent efficacy against experimental murine septicemia caused by Staphylococcus aureus, Streptococcus pyogenes, and Escherichia coli and against murine respiratory infections caused by Streptococcus pneumoniae. Likewise, in murine models of respiratory infection by penicillin-susceptible and penicillin-resistant S. pneumoniae, sanfetrinem cilexetil was more effective than amoxicillin in reducing the number of bacteria in infected lungs. These results were reflected in its potent in vitro activity and high levels in plasma.
